Meta-analysis of tissue expression profiling data from Oncomine database (www.oncomine.org) suggested that the expressions of Nrf2 and several GST mu genes are also gradually down-regulated in human prostate cancers [11]. Here, NFE2L2 is linked to prostate cancer.